M.I.P.Ramos Supplementary Figure 2

1
M.I.P.Ramos Supplementary Figure 2 A B C Intracelullar Extracelullar % MFI % MFI PB HI PB RA SF RA 0 5 10 15 20 % CD4+ Flt3L+ PB HI PB RA SF RA 0 1000 2000 3000 4000 MFI Flt3L PB HI PB RA SF RA 0.0 0.5 1.0 1.5 2.0 % CD4+ Flt3L PB HI PB RA SF RA 0 5000 10000 15000 MFI Flt3L PB HI PB RA SF RA 0 5 10 15 % CD8+ Flt3L+ PB HI PB RA SF RA 0 1000 2000 3000 4000 MFI Flt3L PB HI PB RA SF RA 0.0 0.5 1.0 1.5 2.0 % CD8+ Flt3L PB HI PB RA SF RA 0 2000 4000 6000 8000 10000 MFI Flt3L CD4 + Tcells CD8 + T cells CD19 + B cells PB HI PB RA SF RA 0 1 2 3 4 5 % CD19+ Flt3L+ PB HI PB RA SF RA 0 1000 2000 3000 MFI Flt3L PB HI PB RA SF RA 0 50 100 150 % CD19+ Flt3L PB HI PB RA SF RA 0 5000 10000 15000 MFI Flt3L

description

4000. 20. 2.0. 15000. 3000. 15. 1.5. 10000. % CD4+ Flt3L. % CD4+ Flt3L+. MFI Flt3L. MFI Flt3L. 10. 2000. 1.0. 5000. 0.5. 5. 1000. 0.0. 0. 0. 0. PB HI. PB RA. SF RA. PB HI. PB RA. SF RA. PB HI. PB RA. SF RA. PB HI. PB RA. SF RA. 4000. 2.0. 10000. 15. 8000. - PowerPoint PPT Presentation

Transcript of M.I.P.Ramos Supplementary Figure 2

Page 1: M.I.P.Ramos Supplementary Figure 2

M.I.P.Ramos Supplementary Figure 2

A

B

C

IntracelullarExtracelullar

% MFI % MFI

PB HI PB RA SF RA0

5

10

15

20

% C

D4

+ F

lt3

L+

PB HI PB RA SF RA0

1000

2000

3000

4000

MF

I F

lt3

L

PB HI PB RA SF RA0.0

0.5

1.0

1.5

2.0

% C

D4

+ F

lt3

L

PB HI PB RA SF RA0

5000

10000

15000

MF

I F

lt3

L

PB HI PB RA SF RA0

5

10

15

% C

D8

+ F

lt3

L+

PB HI PB RA SF RA0

1000

2000

3000

4000

MF

I F

lt3

L

PB HI PB RA SF RA0.0

0.5

1.0

1.5

2.0

% C

D8

+ F

lt3

L

PB HI PB RA SF RA0

2000

4000

6000

8000

10000

MF

I F

lt3

L

CD

4+ T

cells

CD

8+ T

cel

lsC

D19

+ B

cel

ls

PB HI PB RA SF RA0

1

2

3

4

5

% C

D1

9+ F

lt3L

+

PB HI PB RA SF RA0

1000

2000

3000

MF

I F

lt3

L

PB HI PB RA SF RA0

50

100

150

% C

D1

9+ F

lt3L

PB HI PB RA SF RA0

5000

10000

15000

MF

I F

lt3

L

SUPPLEMENTARY INFORMATIONmendel.stanford.edu/SidowLab/pdfs/2011ValouevEtAl_Supp.pdf · Supplementary Figure 2 Supplementary Figure 2. Schematic representation of in vitro reconstitution

SUPPLEMENTARY INFORMATIONmendel.stanford.edu/SidowLab/pdfs/2011ValouevEtAl_Supp.pdf · Supplementary Figure 2 Supplementary Figure 2. Schematic representation of in vitro reconstitution

Supplementary Figure 1. Supplementary Figure 2 Supplementary Figure 3 A B.

Supplementary Figure 1. Supplementary Figure 2 Supplementary Figure 3 A B.

Supplementary Figure 2

Supplementary Figure 2

Supplementary Information Supplementary Figure S1. Phenotypic … · 2013-02-05 · 2 Supplementary Figures and Legends Fig.S1 Supplementary Figure S1. Phenotypic comparison of the

Supplementary Information Supplementary Figure S1. Phenotypic … · 2013-02-05 · 2 Supplementary Figures and Legends Fig.S1 Supplementary Figure S1. Phenotypic comparison of the

images.nature.com · Web viewSupplementary Figure 7 Supplementary Figure 3 Supplementary Figure 1 Supplementary Materials Supplementary Figures S1-S7 Supplementary Tables S1-S7 Clinical

images.nature.com · Web viewSupplementary Figure 7 Supplementary Figure 3 Supplementary Figure 1 Supplementary Materials Supplementary Figures S1-S7 Supplementary Tables S1-S7 Clinical

Supplementary Figure 1A HNF4AWNT5AVANGL1PCLB1 Supplementary Figure 1B Supplementary Figure 1. (A) HNF4A TFBSs of the three genes: VANGL1, WNT5A and PLCB1.

Supplementary Figure 1A HNF4AWNT5AVANGL1PCLB1 Supplementary Figure 1B Supplementary Figure 1. (A) HNF4A TFBSs of the three genes: VANGL1, WNT5A and PLCB1.

media.nature.com · 1 Supplementary Materials Supplementary Table S1 Supplementary Table S2 Supplementary Table S3 Supplementary Figure S1 Supplementary Figure S2 Supplementary Figure

media.nature.com · 1 Supplementary Materials Supplementary Table S1 Supplementary Table S2 Supplementary Table S3 Supplementary Figure S1 Supplementary Figure S2 Supplementary Figure

Supplementary Figure 2A

Supplementary Figure 2A

Supplementary Figure 1 - Welcome to the UCLA …€¦ ·  · 2016-06-151 Supplementary Figure 1 Supplementary Figure 1. ... Supplementary Figure 5 Supplementary Figure 5. ... JP10089

Supplementary Figure 1 - Welcome to the UCLA …€¦ ·  · 2016-06-151 Supplementary Figure 1 Supplementary Figure 1. ... Supplementary Figure 5 Supplementary Figure 5. ... JP10089

Supplementary Information SUPPLEMENTARY … · SUPPLEMENTARY INFORMATION 2 | RESEARCH Supplementary Information 3 Fig. S2 Figure S2: Carbon Rearrangement Networks Used in Various

Supplementary Information SUPPLEMENTARY … · SUPPLEMENTARY INFORMATION 2 | RESEARCH Supplementary Information 3 Fig. S2 Figure S2: Carbon Rearrangement Networks Used in Various

Supplementary Figure S26.

Supplementary Figure S26.

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure · 2015. 1. 14. · 2 Supplementary Figure Supplementary Figure 1. Standard and Selected Samples. Chen et al. (2015) Asian Australas. J. Anim. Sci. 28:158-165

Supplementary Figure · 2015. 1. 14. · 2 Supplementary Figure Supplementary Figure 1. Standard and Selected Samples. Chen et al. (2015) Asian Australas. J. Anim. Sci. 28:158-165

Supplementary Materials Supplementary Figure Legends ...

Supplementary Materials Supplementary Figure Legends ...

Supplementary figure 2.

Supplementary figure 2.

Supplementary Figure S1

Supplementary Figure S1

SUPPLEMENTARY MATERIAL: SUPPLEMENTARY FIGURE 2cambridge.org:id:article:S... · SUPPLEMENTARY MATERIAL: SUPPLEMENTARY FIGURE 2 Image gallery to accompany John Robb (2015), “Prehistoric

SUPPLEMENTARY MATERIAL: SUPPLEMENTARY FIGURE 2cambridge.org:id:article:S... · SUPPLEMENTARY MATERIAL: SUPPLEMENTARY FIGURE 2 Image gallery to accompany John Robb (2015), “Prehistoric

Supplementary figure 5

Supplementary figure 5

Supplementary Figure 2. Kunogi M et al.

Supplementary Figure 2. Kunogi M et al.

Supplementary Figure 1 - dm5migu4zj3pb.cloudfront.net · Supplementary Figure 1 A B 0 10 20 30 40 ... Oral glucose tolerance test (OGTT) ... Supplementary Figure 2 A) ) 0.5 0 1 1.5

Supplementary Figure 1 - dm5migu4zj3pb.cloudfront.net · Supplementary Figure 1 A B 0 10 20 30 40 ... Oral glucose tolerance test (OGTT) ... Supplementary Figure 2 A) ) 0.5 0 1 1.5